This is just for the Pre-sale raise, not the general public token sale.
General public token sale Begins March 1, 2018.
AMCHART is a universal electronic health record (EHR) that’s poised to change the way we access patient and provider records. It utilizes blockchain technology to eliminate the current problems with record systems, improving portability and migration of information, as well as transparency and accessibility. Our main objectives are for patients to have full control over their health records, and providers to have increased confidence that blockchain technology can provide to finally make the system whole.
AMCHART is a patient driven EHR on a hybrid public/private blockchain with AI for analytics and an incentive drive model for better outcomes. The incentive drive model is based on maintenance of health records, wellness program participation, population health, and data sharing with certified partners for analytics and proactive healthcare management. The consensus security is based on Intel SGX chips and running the consensus directly on hardware not only provides extra security, but also accelerates transaction times and stabilizes our ability to decentralize the medical record appropriately. AMCHART with be utilizing Ethereum based Smart contracts and a Hyperledger Sawtooth framework to create a secure pathway to access patient data for both patients and providers.
AMCHART is being built, tested, and rolled out to industry in three phases, the first of which is already underway:
This will be the initial MVP (minimal viable product) with the security structures enabled. Both providers and patients will be able to have access and patients can create medical records, create permissioned access, and build upon the medical records. This will occur by mid to late January 2018. We will also begin the process of developing our mobile application and testing wearables for real time patient monitoring of heart rate, blood pressure, O2 sat, weight, blood sugar, and heart health during this time for initiating wellness programs.
Includes further data collection, as well as the additional layering of machine learning/AI in conjunction with diagnostic and history sets (family, social, medical), to proactively manage health-related issues. Our goal is to leverage existing technologies to promote wellness and management of population health, even before symptoms occur.
We will have full activation of wellness programs with app usage and real-time monitoring and access of data through the EHR. We will have full AI capabilities to assist all organizations to answer the questions they want to address about the healthcare cycle (disease processes, medication usage, wellness management, proactive diagnosis, etc.). Also, we will begin integration of billing components and payment processing from payors to providers through blockchain intermediaries.
Aman’s nearly 15-year career blends education, training, and experience in the medical field (including a Doctor of Physical Therapy degree from Texas Tech University) with leadership of groundbreaking tech initiatives in blockchain, cryptocurrency, and healthcare. Concurrent with his tenure as CEO of AMSYS Blockchain/Cryptocurrency, he serves as a managing partner for a full-service backend health servicing company with specialties ranging from IT to record transcription to compliance testing.
Choka’s educational and professional experience began with a degree in computer science and engineering in 1998, and has progressed through service as a principal consultant, a solutions architect for a healthcare technology firm, an IT advisory board member, and a principle for a big-data solutions company specializing in medical applications. As CTO of AMSYS Blockchain, Choka is responsible for oversight of the development, testing, and rollout of the AMCHART tool as well as leadership of multiple private and public blockchain initiatives.
Ken is the founder, chairman, and CEO of AMSYS, a 15-year-old international organization invested in six principle verticals including AMChart. A thought leader in IT development and deployment, he’s also served as chairman of a healthcare smart solutions provider. In addition to his work as AMSYS chairman, he’s the CIO of an investment firm as well. Ken has a proven track record of successfully starting healthcare and tech companies, and turning them into multimillion-dollar juggernauts.
The driving force behind AMCHART is AMSYS—embodying 15 years of corporate excellence based on shared principles of integrity, honor, and mutual gain, and making decisions with an eye to the future while always seeking the prosperity of our employees, clients, or partners. With two offices in the U.S. including our world headquarters in Houston TX, as well as several other locations in India and the Middle East, AMSYS is an international group invested in six principle verticals backed by a seasoned team with decades of respective experience in each field:
While AMSYS has been recognized with awards from the Houston Business Journal, Ingram Micro, the Fast 50 and Inc. 500/5000, nothing is more important to us than the unconditional satisfaction of our customers, and the success of those who do business with us.
AMSYS’s footprint in the medical industry is already well established with TransWise, a company founded to provide medical practitioners, clinics, and hospitals with affordable solutions to decrease healthcare costs and improve efficiency. This commitment to revolutionizing the world’s healthcare continues with the introduction of AMCHART.
AMCHART has been meticulously planned not just for its development and eventual deployment, but for every cent of every token invested. Click each section of the chart below to learn how token funds will be delineated. It is to be noted that NO FOUNDER of the AMCHART will be receiving tokens during the token sale. There will be two sale periods, one of which will be a pre-sale period for accredited investors to purchase tokens, and a general public token sale which will occur in January 2018.
Based on the monies raised throughout our token sale, AMchart organization will delineate tokens as follows: